Medicina (Oct 2023)

Prognostic Value of Mitral Regurgitation in Patients with Primary Hypertrophic Cardiomyopathy

  • Milorad Tesic,
  • Lazar Travica,
  • Vojislav Giga,
  • Ivana Jovanovic,
  • Danijela Trifunovic Zamaklar,
  • Dejana Popovic,
  • Djordje Mladenovic,
  • Marija Radomirovic,
  • Jelena Vratonjic,
  • Nikola Boskovic,
  • Srdjan Dedic,
  • Olga Nedeljkovic Arsenovic,
  • Srdjan Aleksandric,
  • Stefan Juricic,
  • Branko Beleslin,
  • Ana Djordjevic Dikic

DOI
https://doi.org/10.3390/medicina59101798
Journal volume & issue
Vol. 59, no. 10
p. 1798

Abstract

Read online

Background and Objectives: Mitral valve pathology and mitral regurgitation (MR) are very common in patients with hypertrophic cardiomyopathy (HCM), and the evaluation of mitral valve anatomy and degree of MR is important in patients with HCM. The aim of our study was to examine the potential influence of moderate or moderately severe MR on the prognosis, clinical presentation, and structural characteristics of HCM patients. Materials and Methods: A prospective study examined 176 patients diagnosed with primary asymmetric HCM. According to the severity of the MR, the patients were divided into two groups: Group 1 (n = 116) with no/trace or mild MR and Group 2 (n = 60) with moderate or moderately severe MR. All patients had clinical and echocardiographic examinations, as well as a 24 h Holter ECG. Results: Group 2 had significantly more often the presence of the obstructive type of HCM (p p = 0.030), NYHA II class (p p = 0.023). Also, Group 2 had an enlarged left atrial dimension (p p p p p p p = 0.015). Conclusions: The presence of moderate or moderately severe MR was associated with unfavorable long-term outcomes in HCM patients.

Keywords